Valo Therapeutics Company
Valo Therapeutics is an immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
Employee Number:
11-50
Investors Number:
1
Last Funding Type:
Debt Financing
Founded Date:
2016-01-01
Estimated Revenue:
$10M to $50M
Funding Status:
Seed
Total Funding:
9207932
Last Funding Date:
2020-02-06
Headquarters:
Helsinki, Southern Finland, Finland
Industry:
Viral Vectors